Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandy Macrae currently holds 1,895,043 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandy Macrae has been a net neutral trader of SGMO stock. They have purchased $0 and sold $0 worth of shares.
Sandy Macrae's most recent insider trade was on May 25, 2026, when they sold 12,613 shares at $0.17 per share.
Sandy Macrae serves as Executive at SANGAMO THERAPEUTICS, INC (SGMO). They have executed 31 insider transactions totaling $0 over their tenure at the company.
Sandy Macrae holds the position of Executive at SANGAMO THERAPEUTICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Sandy Macrae has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sandy Macrae was on Feb 25, 2021, when they sold $395.1K worth of SGMO shares. This transaction involved 35,311 shares at $11.19 per share.
Sandy Macrae currently owns 1,895,043 shares of SANGAMO THERAPEUTICS, INC (SGMO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandy Macrae's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandy Macrae has 31 Form 4 filings on record as an insider at SANGAMO THERAPEUTICS, INC.
Set alerts for Sandy Macrae and 40,000+ other insiders.